Operating Lease, Right-of-Use Asset of SOLENO THERAPEUTICS INC from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
SOLENO THERAPEUTICS INC quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • SOLENO THERAPEUTICS INC Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $2,191,000, a 22% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

SOLENO THERAPEUTICS INC Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $2,191,000 -$607,000 -22% 31 Dec 2025 10-K 25 Feb 2026 2025 FY
Q3 2025 $2,314,000 -$678,000 -23% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $2,434,000 +$2,166,000 +808% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $2,603,000 +$2,265,000 +670% 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $2,798,000 +$2,391,000 +587% 31 Dec 2024 10-K 25 Feb 2026 2025 FY
Q3 2024 $2,992,000 +$2,518,000 +531% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $268,000 -$273,000 -50% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $338,000 +$285,000 +538% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $407,000 +$276,000 +211% 31 Dec 2023 10-K 28 Feb 2025 2024 FY
Q3 2023 $474,000 +$268,000 +130% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $541,000 +$262,000 +94% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $53,000 -$297,000 -85% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $131,000 -$290,000 -69% 31 Dec 2022 10-K 07 Mar 2024 2023 FY
Q3 2022 $206,000 -$283,000 -58% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $279,000 -$321,000 -54% 30 Jun 2022 10-Q 10 Aug 2022 2022 Q2
Q1 2022 $350,000 +$300,000 +600% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $421,000 +$297,000 +240% 31 Dec 2021 10-K 22 Mar 2023 2022 FY
Q3 2021 $489,000 +$294,000 +151% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $600,000 +$335,000 +126% 30 Jun 2021 10-Q 09 May 2023 2023 Q1
Q1 2021 $50,000 -$282,000 -85% 31 Mar 2021 10-Q 05 May 2021 2021 Q1
Q4 2020 $124,000 -$274,000 -69% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 $195,000 30 Sep 2020 10-Q 10 Nov 2020 2020 Q3
Q2 2020 $265,000 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $332,000 31 Mar 2020 10-Q 12 May 2020 2020 Q1
Q4 2019 $398,000 31 Dec 2019 10-K 03 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.